Search - tctmd.com

Displaying 401 - 420 of 694

Sort: Relevancy | Date

Presentation TCT 2018

TCT-11: Assessment of the Adenosine-Dependent Hyperemic Response During the Subacute Phase of a Myocardial Infarction: Insights for FFR-Guided Coronary Revascularization in Non-Infarcted-Related Arteries

Presenter: Allen Jeremias, Hernan Mejia-Renteria

September 21, 2018

Presentation TCT 2018

TCT-22: The Residual SYNTAX Score Predicts Prognosis in ST Elevation Myocardial Infarction in Both Single Vessel and Multivessel Disease

Presenter: Angeles Alonso Garcia, Rajesh M. Dave, Sonya Burgess

September 21, 2018

Presentation TCT 2018

TCT-21: Prognostic Impact of SYNTAX II Score in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis of an 8-year All-Comers Registry

Presenter: Angeles Alonso Garcia, Rajesh M. Dave, Ana Belen Cid Alvarez

September 21, 2018

Presentation TCT 2018

Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction: First Results of the CAMI1 Study

Presenter: Ulrich P. Jorde, John M. Lasala, Christoph Garlichs

September 21, 2018

Presentation TCT 2018

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Presentation TCT 2017

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

Presenter: Patrick W. Serruys, Liansheng Wang, MD

November 01, 2017

Presentation TCT 2017

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

Presenter: Patrick W. Serruys, Konstantinos Voudris

November 01, 2017

Presentation TCT 2017

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

Presenter: Patrick W. Serruys, Ori Ben-Yehuda

November 01, 2017

Presentation TCT 2017

Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Pilot Clinical Study

Presenter: Dariusz Dudek, Cindy L. Grines, Liansheng Wang

November 01, 2017

Presentation TCT 2017

Pre and Postconditioning to Enhance Myocardial Salvage: 2017 Status

Presenter: Bernard J. Gersh, Michel Ovize, Graham Nichol

October 31, 2017

Presentation TCT 2017

Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials

Presenter: Bernard J. Gersh, Michel Ovize

October 31, 2017

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

Presentation TCT 2017

First of the Class: Tissue Engineering

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent

October 31, 2017

Presentation TCT 2017

New Strategies for a Chronic Scenario: Combinative Approaches

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Advertisement

TCT-11: Assessment of the Adenosine-Dependent Hyperemic Response During the Subacute Phase of a Myocardial Infarction: Insights for FFR-Guided Coronary Revascularization in Non-Infarcted-Related Arteries

TCT-22: The Residual SYNTAX Score Predicts Prognosis in ST Elevation Myocardial Infarction in Both Single Vessel and Multivessel Disease

TCT-21: Prognostic Impact of SYNTAX II Score in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis of an 8-year All-Comers Registry

Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction: First Results of the CAMI1 Study

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Pilot Clinical Study

Pre and Postconditioning to Enhance Myocardial Salvage: 2017 Status

Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

First of the Class: Tissue Engineering

New Strategies for a Chronic Scenario: Combinative Approaches

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

New Targets: Heart Failure With Preserved Ejection Fraction

In Which Direction is Cell Based Heart Failure Therapy Headed?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content